Clik here to view.
Why Square wound up pricing its IPO so low
There was a lot of hand-wringing on Wednesday night when digital-payments startup Square set its initial public offering price at $9 per share.The price was below the $11 to $13 range Square had...
View ArticleClik here to view.
These 3 slides show just how brutal 2015 has been for Wall Street's biggest...
It has been a rough year for investment banks. And it is all because of the big banks' fixed income, currencies and commodities — or FICC — divisions, which for so long have powered earnings.According...
View ArticleClik here to view.
Blackstone is now 'the largest owner of real estate in the world' (BX)
Blackstone has grown its size nearly four-fold since its 2007 IPO.But the biggest private equity firm on Wall Street has seen even greater growth in its real estate division, which has expanded from a...
View ArticleClik here to view.
What JPMorgan's most senior staff learned from their first jobs (JPM)
Everybody starts somewhere.JPMorgan recently published a series of candid interviews with top executives about what they learned from their first jobs.Long before they started putting together big...
View ArticleClik here to view.
The energy crash is going to be huge business for Wall Street
The energy sector has been getting hammered, and that has Wall Street on high alert.The commodity slump has put a number of companies under pressure. Oil and gas companies are edging toward default,...
View ArticleClik here to view.
Goldman Sachs is trying to address a 'misunderstanding' about the murky...
One part of Goldman Sachs' business got hammered in the third quarter, and people have been asking questions about it ever since.The bank's investing-and-lending business line saw a 60% drop in revenue...
View ArticleClik here to view.
2 big bank CEOs just explained why they're throttling personal-finance...
Big banks have recently throttled popular consumer apps and restricted their access to key data, frustrating their own account holders.And two CEOs just provided a little more insight into why.William...
View ArticleClik here to view.
Wall Street pay has crashed
Wall Street just isn't as remunerative as it used to be.And the chart below, which is based on compensation data from the annual Options Group survey, shows just how much less Wall Streeters earn now...
View ArticleClik here to view.
BOUTIQUE BONANZA: 3 small Wall Street firms grabbed big roles on the...
Pfizer has agreed on a deal to combine with Allergan in a $160 billion transaction that will be among the biggest deals of all time. And three small Wall Street firms are in on the action. Guggenheim...
View ArticleClik here to view.
WALL STREET PAYDAY: Banks could reap up to $350 million on Pfizer-Allergan...
Pfizer is combining with Allergan in a deal worth $160 billion, in what will be the biggest M&A transaction of 2015.And it's great news for Wall Street. There could be more than $350 million in...
View ArticleClik here to view.
The largest takeover of the year is all about avoiding US taxes (PFE, act, AGN)
Pfizer just struck the largest-ever takeover by a drugmaker, a $160 billion merger with Allergan.In addition to best-selling cosmetic drug Botox, the deal gives Pfizer something it has been after for a...
View ArticleClik here to view.
A tiny Wall Street firm advising Pfizer on its giant deal has had an...
It has been a good year for Guggenheim Securities.The 16-year-old firm has been an adviser on five massive transactions in what has been one of the busiest years for mergers and acquisitions on...
View ArticleClik here to view.
A fund led by 'Diva of Distressed' Lynn Tilton has filed for bankruptcy
Lynn Tilton, the so-called Diva of Distressed, announced late Sunday that her Zohar I credit fund was filing for Chapter 11 bankruptcy.The fund, which is structured as a collateralized loan obligation,...
View ArticleClik here to view.
PFIZER CEO: 'This is a great deal for America' (PFE, AGN)
Drug giant Pfizer is merging with Irish-based Allergan in a controversial deal aimed, at least in part, at avoiding US taxes.But Pfizer's CEO doesn't want you to see it that way."First of all, I would...
View ArticleClik here to view.
Another Chinese executive has vanished
Yim Fung, CEO of $20 billion Hong Kong financial firm Guotai Junan International Holdings, has vanished.On Monday, the firm informed regulators that it is selecting temporary replacements for the...
View ArticleClik here to view.
A 7-year deal spree led to the biggest pharma merger ever — and it all...
Pfizer and Allergan will combine in a $160 billion merger. The deal will create a pharmaceutical giant, with drugs from Botox to Viagra in one portfolio.It will also allow Pfizer to reincorporate in...
View ArticleClik here to view.
A biotech stock run by Martin Shkreli is up more than 100% today
KaloBios, a small biopharmaceutical company that received a massive investment from controversial biotech CEO Martin Shkreli, has surged more than 4,900% in the last week.The share price of KaloBios...
View ArticleClik here to view.
Bill Ackman just boosted his stake in Valeant to 9.9% from 5.7%
Bill Ackman's hedge fund, Pershing Square Capital Management, has boosted its stake in Valeant to 9.9% from 5.7%, according to an SEC filing.The firm raised its holdings to 34,118,551 shares, according...
View ArticleClik here to view.
We asked 4 Wall Street recruiters about the hottest trends in hiring
Winter is coming to Wall Street.That means hiring is slowing down and the biggest banks are starting to think about their plans for next year.Business Insider asked senior figures at four Wall Street...
View ArticleClik here to view.
What JPMorgan's most senior staff learned from their first jobs (JPM)
Everybody starts somewhere.JPMorgan recently published a series of candid interviews with top executives about what they learned from their first jobs.Long before they started putting together big...
View Article